Phathom Pharmaceuticals Inc (PHAT)
EBITDA Margin
-14.66%
TTM · Period ending:
PHAT EBITDA Margin
Latest reported-14.66%period ending
Latest reported-14.66%period ending
PHAT EBITDA Margin (0.00% → -14.66%)
Annual ebitda margin
High-resolution chart · PNG
PHAT ebitda margin history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Margin |
|---|---|
| -87.0875% | |
| -473.3259% | |
| -23,320.9677% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |